It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Although serum uric acid (UA) has been reported to be positively associated with increased arterial stiffness as evaluated by cardio-ankle vascular index (CAVI), UA also has an antioxidative effect that prevents endothelial damage. Therefore, the status of endothelial repair induced by endothelial damage might affect the correlation between UA and CAVI. To clarify the correlation between UA and CAVI in relation to endothelial repair activity, we performed a cross-sectional study with 246 Japanese men aged 60–69 years undergoing a general health check-up. The analysis was stratified by the median circulating level of CD34-positive cells because circulating levels of CD34-positive cells could indicate the degree of endothelial repair activity. Independent of known cardiovascular risk factors, among participants with high circulating levels of CD34-positive cells (0.95 cells/μL ≤), UA was significantly positively correlated with CAVI (standardized parameter estimate β = 0.23, p = 0.009), but not among participants with low circulating levels of CD34-positive cells (< 0.95 cells/μL) (β = 0.07, p = 0.445). Independent of established cardiovascular risk factors, UA levels were significantly positively correlated with increased arterial stiffness only among participants with aggressive endothelial repair as evaluated by circulating levels of CD34-positive cells. These results might help clarify some background mechanisms related to endothelial activity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Nagasaki University Graduate School of Biomedical Sciences, Department of General Medicine, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Osaka Institute of Public Health, Epidemiology Section, Division of Public Health, Osaka, Japan (GRID:grid.416993.0) (ISNI:0000 0004 0629 2067)
2 Nagasaki University Graduate School of Biomedical Sciences, Department of Community Medicine, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Nagasaki University Graduate School of Biomedical Sciences, Leading Medical Research Core Unit, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
3 Nagasaki University Graduate School of Biomedical Sciences, Department of General Medicine, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Nagasaki University Graduate School of Biomedical Sciences, Leading Medical Research Core Unit, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
4 Nagasaki University Graduate School of Biomedical Sciences, Department of General Medicine, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
5 Nagasaki University Graduate School of Biomedical Sciences, Leading Medical Research Core Unit, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Nagasaki University, Division of Strategic Collaborative Research, Atomic Bomb Disease Institute, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)
6 Nagasaki University Graduate School of Biomedical Sciences, Department of General Medicine, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Nagasaki University Graduate School of Biomedical Sciences, Leading Medical Research Core Unit, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273); Nagasaki University Graduate School of Biomedical Sciences, Department of Islands and Community Medicine, Nagasaki, Japan (GRID:grid.174567.6) (ISNI:0000 0000 8902 2273)